Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. reports developments tied to its beauty and wellness business, affiliate opportunity platform and international market operations. Company updates commonly cover quarterly revenue and earnings, customer, paid affiliate and sales leader trends, dividend declarations, cost discipline and product commercialization across Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging brands.
Recurring news also includes the rollout of Prysm iO, an intelligent wellness platform that uses skin scans to provide antioxidant-related insights, and activity at Rhyz, the company’s strategic investment arm for consumer, technology and manufacturing businesses in beauty, wellness and lifestyle categories. Leadership appointments and operating-structure changes are also part of the company’s public updates.
Nu Skin Enterprises (NYSE: NUS) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly performance and upcoming business initiatives.
The financial presentation and conference call will be accessible via webcast on the company's investor relations website at ir.nuskin.com. A replay option will remain available through Thursday, May 22.
Nu Skin Enterprises (NYSE: NUS) reported Q4 2024 revenue of $445.6 million, down 8.8% year-over-year but above company guidance, with a 4.1% FX impact. Q4 EPS was $(0.73), or $0.38 excluding restructuring charges. Full-year 2024 revenue reached $1.73 billion, declining 12% with a 3.8% FX impact.
The company's Rhyz segment showed strong growth, with Q4 revenue of $83.1 million (+27.7%) and full-year revenue of $286.6 million (+32.3%). Customer base decreased 15% to 831,972, with paid affiliates down 13% and sales leaders declining 16%.
For 2025, Nu Skin projects revenue between $1.48-$1.62 billion, expecting a 3% FX headwind. Q1 2025 revenue guidance is $345-365 million, with EPS forecast of $2.65-$2.75, or $0.10-$0.20 excluding the Mavely transaction gain.
Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on March 5, 2025, to shareholders of record as of February 24, 2025.
Nu Skin Enterprises (NYSE: NUS) has announced that its Q4 2024 preliminary revenue is at the high end of the company's guidance range. This announcement comes ahead of its presentation at the ICR Conference on Jan. 14, where President and CEO Ryan Napierski, along with CFO James Thomas, will discuss the company's strategy and performance, including the recent strategic acquisition of Mavely for $250 million. The presentation will be webcast live at 3 p.m. ET on the company's investor relations page, with an archive available through Jan. 28.
Nu Skin will release its full Q4 and full year 2024 financial results after market close on Feb. 13. Following the release, the management team will host a conference call at 5 p.m. ET, which will also be webcast live on the investor relations page. A replay will be accessible through Feb. 27.
Nu Skin Enterprises (NYSE: NUS) announced that its subsidiary Rhyz Inc. has completed a strategic transaction with Later, selling its Mavely affiliate marketing technology platform for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. Of this amount, $33 million will be distributed to other Mavely equity holders.
The transaction represents a five-times return on Nu Skin's investment since acquiring Mavely in 2021. Mavely will continue providing technology and social commerce capabilities to support Nu Skin's affiliate marketing business. The company plans to use the proceeds to reduce debt, fund innovation, and repurchase shares under its existing stock buyback program.
Later, a leader in influencer marketing and social media management, has acquired Mavely for $250 million, funded by Summit Partners. The acquisition from Nu Skin Enterprises (NYSE:NUS) subsidiary Rhyz Inc enhances Later's capabilities in creator-driven marketing, combining Later's AI predictive analytics with Mavely's network of over 120,000 creators who have generated more than $1 billion in gross merchandising volume across 1,400+ major brands.
The merger aims to deliver full-funnel impact and measurable ROI for marketers while enabling creators to maximize earnings through social commerce. Mavely's leadership team, including CEO Evan Wray, CTO Sean O'Brien, and CFO Kevin Kenefick, will join Later's leadership team. The combined platform will focus on enhancing creator collaboration and helping marketers deliver measurable results with greater confidence.
Nu Skin Enterprises (NYSE: NUS) reported Q3 2024 revenue of $430.1 million, down 13.8% year-over-year, with a 3.4% FX impact. The company's Rhyz segment showed strong growth of 20.9%, reaching $73.1 million. Earnings per share were $0.17 compared to $(0.74) in the prior year. Customer base declined 15% to 831,768, while paid affiliates decreased 20%. The company is implementing a revised business model and streamlined operating framework to improve profitability. For full-year 2024, Nu Skin adjusted its outlook to revenue between $1.70-$1.73 billion and EPS of $(2.32)-$(2.22), or $0.65-$0.75 non-GAAP.
Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on December 11, 2024, to shareholders of record as of November 29, 2024.
Later, a leading social media and influencer marketing partner, has partnered with Mavely to introduce affiliate campaign capabilities for creator campaigns. This integration combines Mavely's performance-based affiliate marketing with Later's influencer marketing platform to address the challenge of measuring full-funnel impact. The partnership allows brands using popular affiliate networks to enable creators to drive social commerce through Later campaigns, providing a single view of traffic, orders, revenue, and cost by campaign and creator.
Key features include:
- Automatic generation and assignment of unique affiliate links to creators
- Attribution of sales to specific creators
- Integration with Later's Link in Bio for creators to feature affiliate products
- No technical implementation required for rapid setup
This move aligns with Later's vision of driving predictable outcomes for social commerce and follows their earlier launch of AI-enabled social listening.
Nu Skin Enterprises (NYSE: NUS) has introduced MYND360, a new line of clinically proven supplements and topicals for mental well-being. The product line is the result of five years of research and includes six products designed to support sleep, stress management, focus, and memory.
Key products in the MYND360 line include:
- Feel Calm: Supports mood and stress reduction
- Mind Full: Protects against mental fatigue and supports memory
- Night Time: Aids in sleep quality and duration
- Sharp Focus: Supports brain function and concentration
- Relaxing Body Cream and Energizing Hand and Body Wash
Nu Skin conducted three clinical studies on key ingredient blends, demonstrating significant improvements in sleep quality, stress reduction, and memory performance. The company also emphasizes its commitment to sustainability, with some products featuring innovative packaging that uses 81% less plastic and produces 81% lower carbon emissions.